Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin2015658710825651787
   PubMed Web of Science ®Google Scholar
• LlovetJMRealMIMontañaXArterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialLancet20023591734173912049862
   PubMed Web of Science ®Google Scholar
• TakayasuKAriiSIkaiIProspective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patientsGastroenterology200613146146916890600
   PubMed Web of Science ®Google Scholar
• OkusakaTKasugaiHShioyamaYTransarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trialJ Hepatol2009511030103619864035
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology2011531020102221374666
   PubMed Web of Science ®Google Scholar
• KokudoNHasegawaKAkahaneMEvidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)Hepatol Res201545
   PubMed Web of Science ®Google Scholar
• OgasawaraSChibaTOokaYA prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolizationPLoS One201510e012524425919025
   PubMed Web of Science ®Google Scholar
• BarmanPMSharmaPKrishnamurthyVPredictors of mortality in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationDig Dis Sci2014592821282524973040
   PubMed Web of Science ®Google Scholar
• HuHTKimJHLeeLSChemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohortJ Vasc Interv Radiol20112291792321571545
   PubMed Web of Science ®Google Scholar
• IkedaMMaedaSAshiharaHNagahamaHTanakaMSasakiYTranscatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinomaJ Gastroenterol201045606719655081
   PubMed Web of Science ®Google Scholar
• IritaniSImaiKTakaiKSkeletal muscle depletion is an independent prognostic factor for hepatocellular carcinomaJ Gastroenterol20155032333224817668
   PubMed Web of Science ®Google Scholar
• FujiwaraNNakagawaHKudoYSarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinomaJ Hepatol20156313114025724366
   PubMed Web of Science ®Google Scholar
• CalleEERodriguezCWalker-ThurmondKThunMJOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adultsN Engl J Med20033481625163812711737
   PubMed Web of Science ®Google Scholar
• OhkiTTateishiRShiinaSVisceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASHGut20095883984419174415
   PubMed Web of Science ®Google Scholar
• ItohSShirabeKMatsumotoYEffect of body composition on outcomes after hepatic resection for hepatocellular carcinomaAnn Surg Oncol2014213063306824719020
   PubMed Web of Science ®Google Scholar
• HigashiTHayashiHKaidaTPrognostic impact of visceral fat amount and branched-chain amino acids (BCAA) in hepatocellular carcinomaAnn Surg Oncol201522S1041S104726305023
   PubMed Web of Science ®Google Scholar
• NaultJCPigneurFNelsonACVisceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitorsDig Liver Dis20154786987626211871
   PubMedGoogle Scholar
• European Association For The Study Of The LiverEuropean Organisation For Research And Treatment Of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol20125690894322424438
   PubMed Web of Science ®Google Scholar
• MitsiopoulosNBaumgartnerRNHeymsfieldSBLyonsWGallagherDRossRCadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomographyJ Appl Physiol (1985)1998851151229655763
   PubMed Web of Science ®Google Scholar
• MillerKDJonesEYanovskiJAShankarRFeuersteinIFalloonJVisceral abdominal-fat accumulation associated with use of indinavirLancet19983518718759525365
   PubMed Web of Science ®Google Scholar
• NishikawaHShirakiMHiramatsuAMoriyaKHinoKNishiguchiSJapan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteriaHepatol Res20164695196327481650
   PubMed Web of Science ®Google Scholar
• PradoCMLieffersJRMcCargarLJPrevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyLancet Oncol2008962963518539529
   PubMed Web of Science ®Google Scholar
• van VledderMGLevolgerSAyezNVerhoefCTranTCIjzermansJNBody composition and outcome in patients undergoing resection of colorectal liver metastasesBr J Surg20129955055722246799
   PubMed Web of Science ®Google Scholar
• Liver Cancer Study Group of JapanGeneral Rules for the Clinical and Pathological Study of Primary Liver Cancer3rd English edTokyoKanehara20102627
   Google Scholar
• LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis201030526020175033
   PubMed Web of Science ®Google Scholar
• TsoliMSwarbrickMMRobertsonGRLipolytic and thermogenic depletion of adipose tissue in cancer cachexiaSemin Cell Dev Biol201654688126529279
   PubMed Web of Science ®Google Scholar
• BatistaMLJrNevesRXPeresSBHeterogeneous time-dependent response of adipose tissue during the development of cancer cachexiaJ Endocrinol201221536337323033362
   PubMed Web of Science ®Google Scholar
• DahlmanIMejhertNLinderKAdipose tissue pathways involved in weight loss of cancer cachexiaBr J Cancer20101021541154820407445
   PubMed Web of Science ®Google Scholar
• BingCRussellSBecketEAdipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing miceBr J Cancer2006951028103717047651
   PubMed Web of Science ®Google Scholar
• Zuijdgeest-van LeeuwenSDvan den BergJWWattimenaJLLipolysis and lipid oxidation in weight-losing cancer patients and healthy subjectsMetabolism20004993193610910006
   PubMed Web of Science ®Google Scholar
• MurphyRAWilkeMSPerrineMLoss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patientsClin Nutr20102948248719959263
   PubMed Web of Science ®Google Scholar
• CamusVLanicHKrautJPrognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapyEur J Haematol201493918
   PubMed Web of Science ®Google Scholar
• CooperABSlackRFogelmanDCharacterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancerAnn Surg Oncol2015222416242325519927
   PubMed Web of Science ®Google Scholar
• IbrahimMMSubcutaneous and visceral adipose tissue: structural and functional differencesObes Rev201011111819656312
   PubMed Web of Science ®Google Scholar
• TranTTYamamotoYGestaSKahnCRBeneficial effects of subcutaneous fat transplantation on metabolismCell Metab2008741042018460332
   PubMed Web of Science ®Google Scholar
• WuWLiuXChaftariPAssociation of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective reviewPLoS One201510e012204725822612
   PubMed Web of Science ®Google Scholar
• GrignolVPSmithADShlapakDZhangXDel CampoSMCarsonWEIncreased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapySurg Oncol20152435335826690825
   PubMed Web of Science ®Google Scholar
• OkamuraAWatanabeMMineSClinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinomaAnn Surg Oncol2016231387139426668084
   PubMed Web of Science ®Google Scholar
• CabiaBAndradeSCarreiraMCCasanuevaFFCrujeirasABA role for novel adipose tissue-secreted factors in obesity-related carcinogenesisObes Rev20161736137626914773
   PubMed Web of Science ®Google Scholar
• ParkEJLeeJHYuGYDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionCell201014019720820141834
   PubMed Web of Science ®Google Scholar
• SharmaDWangJFuPPAdiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesisHepatology2010521713172220941777
   PubMed Web of Science ®Google Scholar
• HarimotoNShirabeKYamashitaYISarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinomaBr J Surg20131001523153024037576
   PubMed Web of Science ®Google Scholar
• LevolgerSvan VledderMGMuslemRSarcopenia impairs survival in patients with potentially curable hepatocellular carcinomaJ Surg Oncol201511220821326266324
   PubMed Web of Science ®Google Scholar
• KamachiSMizutaTOtsukaTSarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatmentHepatol Res20164620120826223826
   PubMed Web of Science ®Google Scholar
• YabusakiNFujiiTYamadaSAdverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resectionInt J Surg20163013614227154615
   PubMed Web of Science ®Google Scholar
• HarimotoNYoshizumiTShimokawaMSarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinomaHepatol Res2016461247125526880049
   PubMed Web of Science ®Google Scholar
• AntounSBayarAIleanaEHigh subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingEur J Cancer2015512570257726278649
   PubMed Web of Science ®Google Scholar
• TakeokaYSakatokuKMiuraAPrognostic effect of low subcutaneous adipose tissue on survival outcome in patients with multiple myelomaClin Lymphoma Myeloma Leuk20161643444127263047
   PubMed Web of Science ®Google Scholar